| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/13/2001 | CA2401323A1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | CA2401239A1 Improved poloxamer and poloxamine compositions for nucleic acid delivery |
| 09/13/2001 | CA2400628A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 09/13/2001 | CA2399943A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | CA2399921A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | CA2399913A1 Adam polynucleotides, polypeptides, and antibodies |
| 09/12/2001 | EP1132478A2 Helper virus for the preparation of recombinant viral recombinants |
| 09/12/2001 | EP1132403A1 Tgf g beta1 inhibitor peptides |
| 09/12/2001 | EP1132099A1 Nucleic acid transporters and medicinal compositions for gene therapy |
| 09/12/2001 | EP1132098A1 Gene therapy for cerebrovascular disorders |
| 09/12/2001 | EP1132091A1 Treatment for diabetes |
| 09/12/2001 | EP1131467A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 09/12/2001 | EP1131458A1 Viral vectors with late transgene expression |
| 09/12/2001 | EP1131457A1 Systemic viral/ligand gene delivery system and gene therapy |
| 09/12/2001 | EP1131436A1 Urotensins ii of mammals and their uses |
| 09/12/2001 | EP1131432A2 Cell surface receptor antigen vaccines |
| 09/12/2001 | EP1131430A2 Mitogenic regulators |
| 09/12/2001 | EP1131426A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
| 09/12/2001 | EP1131425A2 Inflammation-associated genes |
| 09/12/2001 | EP1131411A2 Suppression of xenotransplant rejection |
| 09/12/2001 | EP1131406A2 Low oxygen culturing of central nervous system progenitor cells |
| 09/12/2001 | EP1131354A1 Contraceptive antibody vaccines |
| 09/12/2001 | EP1131353A1 Intracellular c-terminal hdl-receptor domain |
| 09/12/2001 | EP1131350A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 09/12/2001 | EP1131334A1 Use of core 2 glcnac transferase inhibitors in treating inflammation |
| 09/12/2001 | EP1131333A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF |
| 09/12/2001 | EP1131090A2 Method of using pon-1 to decrease atheroma formation |
| 09/12/2001 | EP1131087A2 Methods of alleviating cancer symptoms |
| 09/12/2001 | EP1131086A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
| 09/12/2001 | EP1131085A2 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 09/12/2001 | EP1130969A1 Murf2 polypeptides and polynucleotides |
| 09/12/2001 | EP0839206B1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 09/12/2001 | EP0804452B1 Recombinant c140 receptor, its agonists and antagonists |
| 09/12/2001 | EP0586474B1 Peptide nucleic acids |
| 09/12/2001 | CN1312856A Enzymatic nucleic acid treamtent of diseases or conditions related to hepatitisc virus infection |
| 09/12/2001 | CN1312372A Intocostrin regulation area and nucleotide series determination and method used thereof |
| 09/12/2001 | CN1312272A Human zinc finger protein 32 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312259A Human pax protein 9 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1070866C Superagonists and antagonists and superantagonists of H IL-6, and 3-D modelling method for their selection |
| 09/11/2001 | US6288533 Method and apparatus for detecting rotor position by use of magnetic field sensor pairs |
| 09/11/2001 | US6288306 Methods of selecting plants, plant tissue or plant cells resistant to a protoporphyrinogen oxidase inhibitor |
| 09/11/2001 | US6288218 Detecting gene expression in sample; incubate nucleotide sequences and primers, allow hybridization and detect hybridization products |
| 09/11/2001 | US6288032 Polypeptides for osteoporosis and other bone disorder treatment |
| 09/11/2001 | US6288024 Methods and compositions for inhibiting angiogenesis |
| 09/11/2001 | US6287864 Insertion of nucleotide sequences into preferential cells; infect hematopoietic stem cells with retrovirus, detect expression of preferential gene product |
| 09/11/2001 | US6287863 Method of transferring a DNA sequence to a cell in vitro |
| 09/11/2001 | US6287860 Antisense inhibition of MEKK2 expression |
| 09/11/2001 | US6287858 Nucleotide sequences coding enzymatic polypeptide; for use in the treatment of cell proliferative defects |
| 09/11/2001 | US6287857 Nucleic acid delivery vehicles |
| 09/11/2001 | US6287854 Mammalian expression vector for expression of tumor suppressor gene in human;for the prvention of cell proliferation defects; anticarcinogenic agents; antitumor agents; gene therapy |
| 09/11/2001 | US6287853 Genetically engineered escherichia plasmid; marking antibiotic resistance; artificial chromosomes; genetic mapping |
| 09/11/2001 | US6287836 Histidine kinase from Streptococcus pneumoniae and compositions therecontaining |
| 09/11/2001 | US6287834 Characterization and use of an isolated uridine diphospho-glucuronosyltransferase |
| 09/11/2001 | US6287817 Administering fusion protein of single chain fv molecule against transcytotic receptor linked to therapeutic protein; delivers protein to epithelial cell; treatment of cystic fibrosis |
| 09/11/2001 | US6287804 nrdG |
| 09/11/2001 | US6287802 EXT2 gene |
| 09/11/2001 | US6287786 Nucleic acid molecules encoding a new mammalian protein and to the use of these molecules in the characterization, diagnosis, and treatment of conditions such as disorders associated with cell proliferation, lipid metabolism and transport. |
| 09/11/2001 | US6287777 Several genes expressed differentially between the human prostate carcinoma cell lines lncap and pc-3, which are androgen-dependent and androgen-independent, respectively, have now been isolated. one of these genes, designated npg-1. |
| 09/11/2001 | US6287763 Screening methods for compounds useful in the regulation of body weight |
| 09/11/2001 | US6287591 Stable for theraputic use, hiv, cytomegalo virus, antiinflammatory, antitumor |
| 09/11/2001 | US6287572 Genetic engineering |
| 09/11/2001 | US6287569 Vaccines with enhanced intracellular processing |
| 09/11/2001 | US6287557 Methods of gene therapy using herpes viral vectors expressing GM-CSF |
| 09/11/2001 | CA2166889C Oligonucleotides with activity against human immunodeficiency virus |
| 09/07/2001 | WO2001064949A2 Diagnostics and therapeutics for glaucoma |
| 09/07/2001 | WO2001064930A1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells |
| 09/07/2001 | WO2001064921A1 Melanoma differentiation associated gene - 7 promoter and uses thereof |
| 09/07/2001 | WO2001064908A2 14790, a protein kinase and uses therefor |
| 09/07/2001 | WO2001064906A1 Transferase 32253 and use therefor |
| 09/07/2001 | WO2001064904A2 25324, 50287, 28899, 47007, and 42967 transferase family members and uses therefor |
| 09/07/2001 | WO2001064884A2 G12l, a gene associated with the thermal response |
| 09/07/2001 | WO2001064880A2 Human dynamin 40322 |
| 09/07/2001 | WO2001064877A2 Human schizophrenia gene |
| 09/07/2001 | WO2001064876A2 Human schizophrenia gene |
| 09/07/2001 | WO2001064874A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 09/07/2001 | WO2001064872A2 Gene 2465: methods and compositions for the diagnosis and treatment of cardiovascular, hepatic and bone disease |
| 09/07/2001 | WO2001064870A2 Mutated cyclin g1 protein |
| 09/07/2001 | WO2001064856A2 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding |
| 09/07/2001 | WO2001064750A2 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 09/07/2001 | WO2001064741A2 Methods for selectively modulating survivin apoptosis pathways |
| 09/07/2001 | WO2001064739A1 Tcf responsive element |
| 09/07/2001 | WO2001064738A2 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | WO2001064737A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/07/2001 | WO2001064729A1 A novel polypeptide, human fd 17 and the polynucleotide encoding thereof |
| 09/07/2001 | WO2001064706A1 Antisense modulation of e2f transcription factor 1 expression |
| 09/07/2001 | WO2001064247A2 Method of treating cancer with anti-neurotrophin agents |
| 09/07/2001 | WO2001064240A2 Methods for promoting production of myelin by schwann cells |
| 09/07/2001 | WO2001064238A2 Methods and compositions for regulating adipocytes |
| 09/07/2001 | WO2001064185A2 Method for making, loading and sealing a cell or drug encapsulation device, and such a device |
| 09/07/2001 | WO2001055448A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055447A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055368A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055364A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055355A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055350A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055343A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055328A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055327A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055326A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055326A3 Nucleic acids, proteins, and antibodies |